Picture of bluebird bio logo

BLUE — bluebird bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Bluebird bio to cut 25% of workforce as part of restructuring

Sept 24 (Reuters) - Gene therapy maker bluebird bio
 BLUE.O  said on Tuesday it would cut 25% of its workforce as
part of a restructuring program for cost reduction.

 (Reporting by Christy Santhosh; Editing by Shilpi Majumdar)
 ((Christy.Santhosh@thomsonreuters.com;))

Recent news on bluebird bio

See all news